Abstract

Treatment of drinking water decreases human health risks by reducing pollutants, but the required materials, chemicals, and energy emit pollutants and increase health risks. We explored human carcinogenic and non-carcinogenic disease tradeoffs of water treatment by comparing pollutant dose-response curves against life cycle burden using USEtox methodology. An illustrative wellhead sorbent groundwater treatment system removing hexavalent chromium or pentavalent arsenic serving 3200 people was studied. Reducing pollutant concentrations in drinking water from 20 μg L−1 to 10 μg L−1 avoided 37 potential cancer cases and 64 potential non-cancer disease cases. Human carcinogenicity embedded in treatment was 0.2–5.3 cases, and non-carcinogenic toxicity was 0.2–14.3 cases, depending on technology and degree of treatment. Embedded toxicity impacts from treating Cr(VI) using strong-base anion exchange were <10% of those from using weak base anion exchange. Acidification and neutralization contributed >90% of the toxicity impacts for treatment options requiring pH control. In scenarios where benefits exceeded burdens, tradeoffs still existed. Benefits are experienced by a local population but burdens are born externally where the materials and energy are produced, thus exporting the health risks. Even when burdens clearly exceeded benefits, cost considerations may still drive selecting a detrimental treatment level or technology.

LanguageEnglish (US)
Pages246-254
Number of pages9
JournalWater Research
Volume128
DOIs
StatePublished - Jan 1 2018

Fingerprint

wellhead
health risk
life cycle
toxicity
pollutant
human health
exposure
drinking water treatment
Wellheads
Health risks
Water treatment
Potable water
Toxicity
Life cycle
Health
ion exchange
drinking water
energy
material
Ion exchange

Keywords

  • Arsenic
  • Hexavalent chromium
  • Life cycle assessment
  • Water treatment tradeoffs

ASJC Scopus subject areas

  • Ecological Modeling
  • Water Science and Technology
  • Waste Management and Disposal
  • Pollution

Cite this

@article{2b54c55bfa4745e4bd642e0e692dcaf1,
title = "Human health tradeoffs in wellhead drinking water treatment: Comparing exposure reduction to embedded life cycle risks",
abstract = "Treatment of drinking water decreases human health risks by reducing pollutants, but the required materials, chemicals, and energy emit pollutants and increase health risks. We explored human carcinogenic and non-carcinogenic disease tradeoffs of water treatment by comparing pollutant dose-response curves against life cycle burden using USEtox methodology. An illustrative wellhead sorbent groundwater treatment system removing hexavalent chromium or pentavalent arsenic serving 3200 people was studied. Reducing pollutant concentrations in drinking water from 20 μg L−1 to 10 μg L−1 avoided 37 potential cancer cases and 64 potential non-cancer disease cases. Human carcinogenicity embedded in treatment was 0.2–5.3 cases, and non-carcinogenic toxicity was 0.2–14.3 cases, depending on technology and degree of treatment. Embedded toxicity impacts from treating Cr(VI) using strong-base anion exchange were <10% of those from using weak base anion exchange. Acidification and neutralization contributed >90% of the toxicity impacts for treatment options requiring pH control. In scenarios where benefits exceeded burdens, tradeoffs still existed. Benefits are experienced by a local population but burdens are born externally where the materials and energy are produced, thus exporting the health risks. Even when burdens clearly exceeded benefits, cost considerations may still drive selecting a detrimental treatment level or technology.",
keywords = "Arsenic, Hexavalent chromium, Life cycle assessment, Water treatment tradeoffs",
author = "Mac Gifford and Mikhail Chester and Kiril Hristovski and Paul Westerhoff",
year = "2018",
month = "1",
doi = "10.1016/j.watres.2017.10.014",
volume = "128",
pages = "246--254",
journal = "Water Research",
issn = "0043-1354",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Human health tradeoffs in wellhead drinking water treatment

T2 - Water Research

AU - Gifford,Mac

AU - Chester,Mikhail

AU - Hristovski,Kiril

AU - Westerhoff,Paul

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Treatment of drinking water decreases human health risks by reducing pollutants, but the required materials, chemicals, and energy emit pollutants and increase health risks. We explored human carcinogenic and non-carcinogenic disease tradeoffs of water treatment by comparing pollutant dose-response curves against life cycle burden using USEtox methodology. An illustrative wellhead sorbent groundwater treatment system removing hexavalent chromium or pentavalent arsenic serving 3200 people was studied. Reducing pollutant concentrations in drinking water from 20 μg L−1 to 10 μg L−1 avoided 37 potential cancer cases and 64 potential non-cancer disease cases. Human carcinogenicity embedded in treatment was 0.2–5.3 cases, and non-carcinogenic toxicity was 0.2–14.3 cases, depending on technology and degree of treatment. Embedded toxicity impacts from treating Cr(VI) using strong-base anion exchange were <10% of those from using weak base anion exchange. Acidification and neutralization contributed >90% of the toxicity impacts for treatment options requiring pH control. In scenarios where benefits exceeded burdens, tradeoffs still existed. Benefits are experienced by a local population but burdens are born externally where the materials and energy are produced, thus exporting the health risks. Even when burdens clearly exceeded benefits, cost considerations may still drive selecting a detrimental treatment level or technology.

AB - Treatment of drinking water decreases human health risks by reducing pollutants, but the required materials, chemicals, and energy emit pollutants and increase health risks. We explored human carcinogenic and non-carcinogenic disease tradeoffs of water treatment by comparing pollutant dose-response curves against life cycle burden using USEtox methodology. An illustrative wellhead sorbent groundwater treatment system removing hexavalent chromium or pentavalent arsenic serving 3200 people was studied. Reducing pollutant concentrations in drinking water from 20 μg L−1 to 10 μg L−1 avoided 37 potential cancer cases and 64 potential non-cancer disease cases. Human carcinogenicity embedded in treatment was 0.2–5.3 cases, and non-carcinogenic toxicity was 0.2–14.3 cases, depending on technology and degree of treatment. Embedded toxicity impacts from treating Cr(VI) using strong-base anion exchange were <10% of those from using weak base anion exchange. Acidification and neutralization contributed >90% of the toxicity impacts for treatment options requiring pH control. In scenarios where benefits exceeded burdens, tradeoffs still existed. Benefits are experienced by a local population but burdens are born externally where the materials and energy are produced, thus exporting the health risks. Even when burdens clearly exceeded benefits, cost considerations may still drive selecting a detrimental treatment level or technology.

KW - Arsenic

KW - Hexavalent chromium

KW - Life cycle assessment

KW - Water treatment tradeoffs

UR - http://www.scopus.com/inward/record.url?scp=85032659271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032659271&partnerID=8YFLogxK

U2 - 10.1016/j.watres.2017.10.014

DO - 10.1016/j.watres.2017.10.014

M3 - Article

VL - 128

SP - 246

EP - 254

JO - Water Research

JF - Water Research

SN - 0043-1354

ER -